Startup

RAW Labs SA

Description

RAW Labs SA is a biomedical-technology development company based at the Biopole of Lausanne, Switzerland. The company focuses on bringing early-stage biomedical technologies, including therapeutics and diagnostics, developed in research institutes to the attention of the pharmaceutical industry. Their portfolio includes critical care products designed to combat sepsis and treat severe bacterial and viral infections. One of their key products, CAL02, is a first-in-class anti-virulence agent aimed at treating severe pneumonia by neutralizing virulence effectors that contribute to organ failure and fatal complications in severe infections. RAW Labs SA's innovative approach and cutting-edge technologies have the potential to significantly impact the field of biomedical research and healthcare.

Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.